Zobrazeno 1 - 10
of 26
pro vyhledávání: '"McGuiness CB"'
Autor:
Khatib R, Yeh EJ, Glowacki N, McGuiness CB, Xie H, Wade RL, Kalich BA, Li Y, Rifai A, Sawlani N
Publikováno v:
Clinical Epidemiology, Vol Volume 15, Pp 547-557 (2023)
Rasha Khatib,1 Eric J Yeh,2 Nicole Glowacki,1 Catherine B McGuiness,3 Handing Xie,4 Rolin L Wade,4 Bethany A Kalich,5 Yi Li,6 Abdelhadi Rifai,7 Neal Sawlani8 1Academic Research and Strategic Partnership, Advocate Aurora Research Institute, Advocate A
Externí odkaz:
https://doaj.org/article/c5d129804c2540a1bef1423c1f55b9d0
Publikováno v:
In Value in Health June 2024 27(6) Supplement:S404-S404
Autor:
Camargo CA Jr; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Rane PB; Amgen Inc., Thousand Oaks, California. Electronic address: prane@amgen.com., Beck AF; Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, Ohio., Wang Y; Amgen Inc., Thousand Oaks, California., Chung Y; AstraZeneca, Gaithersburg, Maryland., McGuiness CB; IQVIA, Plymouth Meeting, Pennsylvania., Llanos JP; Amgen Inc., Thousand Oaks, California., Lindsley AW; Amgen Inc., Thousand Oaks, California., Ambrose CS; AstraZeneca, Gaithersburg, Maryland., Zhou Z; IQVIA, Plymouth Meeting, Pennsylvania., Chang HC; IQVIA, Plymouth Meeting, Pennsylvania., Wade RL; IQVIA, Plymouth Meeting, Pennsylvania.
Publikováno v:
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2024 May; Vol. 132 (5), pp. 602-609.e4. Date of Electronic Publication: 2023 Dec 22.
Real-world characteristics of patients with sickle cell disease who initiated crizanlizumab therapy.
Autor:
Desai PC; Hematology, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA., Chen CC; IQVIA Inc, Wayne, PA, USA., McGuiness CB; IQVIA Inc, Wayne, PA, USA., Yasuda M; IQVIA Inc, Wayne, PA, USA., Lee S; Novartis, East Hanover, NJ, USA., Paulose J; Novartis, East Hanover, NJ, USA., He J; IQVIA Inc, Wayne, PA, USA., Yen G; Novartis, East Hanover, NJ, USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2023 Apr; Vol. 39 (4), pp. 555-565. Date of Electronic Publication: 2023 Mar 11.
Autor:
Jahanzeb M; Florida Atlantic University, Boca Raton, FL, USA., Lin HM; Takeda Development Center Americas, Inc., Lexington, MA, USA., Wu Y; Takeda Development Center Americas, Inc., Lexington, MA, USA., Zhang P; Takeda Development Center Americas, Inc., Lexington, MA, USA., Gorritz M; IQVIA, Inc., Wayne, PA, USA., McGuiness CB; IQVIA, Inc., Wayne, PA, USA., Huang WT; IQVIA, Inc., Wayne, PA, USA., Sun K; IQVIA, Inc., Wayne, PA, USA., Chen CC; IQVIA, Inc., Wayne, PA, USA., Camidge DR; University of Colorado, Aurora, CO, USA.
Publikováno v:
The oncologist [Oncologist] 2022 Sep 02; Vol. 27 (9), pp. 790-798.
Autor:
Pandya BJ; Health Economics and Clinical Outcomes Research-Oncology, Astellas Pharma, Inc, Northbrook, IL, USA., Chen CC; Health Economics and Outcomes Research, Real-World Evidence, IQVIA, Plymouth Meeting, PA, USA., McGuiness CB; Health Economics and Outcomes Research, Real-World Evidence, IQVIA, Plymouth Meeting, PA, USA., Sullivan L; Health Economics and Clinical Outcomes Research-Oncology, Astellas Pharma, Inc, Northbrook, IL, USA., Feng Q; Health Economics and Clinical Outcomes Research-Oncology, Astellas Pharma, Inc, Northbrook, IL, USA., Walsh E; Health Economics and Outcomes Research, Real-World Evidence, IQVIA, Plymouth Meeting, PA, USA., Borate U; Oncology, Oregon Health and Science University, Portland, OR, USA.
Publikováno v:
Expert review of hematology [Expert Rev Hematol] 2022 Sep; Vol. 15 (9), pp. 857-866. Date of Electronic Publication: 2022 Aug 04.
Autor:
Settles J; Eli Lilly and Company Corporate Center, Indianapolis, Indiana, USA., Kan H; Eli Lilly and Company Corporate Center, Indianapolis, Indiana, USA., Child CJ; Eli Lilly and Company Corporate Center, Indianapolis, Indiana, USA., Gorritz M; IQVIA Real-World Evidence Solutions, Plymouth Meeting, Plymouth, Pennsylvania, USA., Multani JK; IQVIA Real-World Evidence Solutions, Plymouth Meeting, Plymouth, Pennsylvania, USA., McGuiness CB; IQVIA Real-World Evidence Solutions, Plymouth Meeting, Plymouth, Pennsylvania, USA., Wade RL; IQVIA Real-World Evidence Solutions, Plymouth Meeting, Plymouth, Pennsylvania, USA., Frier BM; Centre for Cardiovascular Science, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2022 Jul; Vol. 24 (7), pp. 1235-1244. Date of Electronic Publication: 2022 Apr 11.
Autor:
Eichenfield LF; Departments of Dermatology and Pediatrics, University of California, San Diego School of Medicine, 3020 Children's Way, Mail Code 5092, San Diego, CA, 92123, USA. leichenfield@ucsd.edu., Armstrong A; Department of Dermatology, Keck School of Medicine at University of Southern California, Los Angeles, CA, USA., Guttman-Yassky E; Mount Sinai Health System, New York, NY, USA., Lio PA; Northwestern University, Chicago, IL, USA., Chen CC; Plymouth Meeting, PA, USA., Hines DM; Plymouth Meeting, PA, USA., McGuiness CB; Plymouth Meeting, PA, USA., Ganguli S; Sanofi, Cambridge, MA, USA., Delevry D; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA., Sierka D; Sanofi, Cambridge, MA, USA., Mallya UG; Sanofi, Cambridge, MA, USA.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2022 Jun; Vol. 12 (6), pp. 1337-1350. Date of Electronic Publication: 2022 May 11.
Publikováno v:
Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2022 Mar-Apr; Vol. 62 (2), pp. 526-536.e10. Date of Electronic Publication: 2021 Nov 12.
Autor:
Armstrong AW; Keck School of Medicine of University of Southern California, Los Angeles, CA, USA., Patil D; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Levi E; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., McGuiness CB; IQVIA, Plymouth Meeting, PA, USA., Wang X; IQVIA, Plymouth Meeting, PA, USA., Wang Y; IQVIA, Plymouth Meeting, PA, USA., Chen CC; IQVIA, Plymouth Meeting, PA, USA., Nguyen E; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Yamauchi PS; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. paulyamauchi@yahoo.com.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2021 Oct; Vol. 11 (5), pp. 1733-1749. Date of Electronic Publication: 2021 Aug 28.